Drug Shortage Report for RETEVMO
| Report ID | 189931 |
| Drug Identification Number | 02516926 |
| Brand name | RETEVMO |
| Common or Proper name | Selpercatinib capsules |
| Company Name | LOXO ONCOLOGY INC |
| Market Status | MARKETED |
| Active Ingredient(s) | |
| Strength(s) | 80MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | Bottle containing 60 capsules |
| ATC code | L01EX |
| ATC description | |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-04-19 |
| Estimated end date | 2023-05-23 |
| Actual end date | 2023-05-23 |
| Shortage status | Resolved |
| Updated date | 2023-05-24 |
| Company comments | For any concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 281 TRESSER BLVD STAMFORD, CONNECTICUT UNITED STATES 06901 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-05-24 | English | Compare |
| v4 | 2023-05-23 | French | Compare |
| v3 | 2023-05-23 | English | Compare |
| v2 | 2023-04-20 | French | Compare |
| v1 | 2023-04-20 | English | Compare |
Showing 1 to 5 of 5